Related references
Note: Only part of the references are listed.Green tea catechin, epigallocatechin-3-gallate (EGCG): Mechanisms, perspectives and clinical applications
Brahma N. Singh et al.
BIOCHEMICAL PHARMACOLOGY (2011)
Oxidative stress and diabetes mellitus
Hui Yang et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2011)
Role of advanced glycation end products (AGEs) and receptor for AGEs (RAGE) in vascular damage in diabetes
Sho-ichi Yamagishi
EXPERIMENTAL GERONTOLOGY (2011)
Epigallocatechin-3-gallate (EGCG) for Clinical Trials: More Pitfalls than Promises?
Derliz Mereles et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2011)
The green tea polyphenol (-)-epigallocatechin-3-gallate ameliorates experimental immune-mediated glomerulonephritis
Ai Peng et al.
KIDNEY INTERNATIONAL (2011)
Intensive Diabetes Therapy and Glomerular Filtration Rate in Type 1 Diabetes
Ian H. de Boer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Beneficial role of telmisartan on cardiovascular complications associated with STZ-induced type 2 diabetes in rats
Bhoomika R. Goyal et al.
PHARMACOLOGICAL REPORTS (2011)
Valsartan attenuated oxidative stress, decreased MCP-1 and TGF-β1 expression in glomerular mesangial and epithelial cells induced by high-glucose levels
Bo Jiao et al.
BIOSCIENCE TRENDS (2011)
Diabetes and alpha lipoic acid
Saeid Golbidi et al.
FRONTIERS IN PHARMACOLOGY (2011)
The RAGE Axis A Fundamental Mechanism Signaling Danger to the Vulnerable Vasculature
Shi Fang Yan et al.
CIRCULATION RESEARCH (2010)
Hyperglycemia-Induced Reactive Oxygen Species Increase Expression of the Receptor for Advanced Glycation End Products (RAGE) and RAGE Ligands
Dachun Yao et al.
DIABETES (2010)
Advanced glycation end products-induced apoptosis attenuated by PPARδ activation and epigallocatechin gallate through NF-κB pathway in human embryonic kidney cells and human mesangial cells
Yao-Jen Liang et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2010)
Green tea polyphenol epigallocatechi3-gallate: Inflammation and arthritis
Rashmi Singh et al.
LIFE SCIENCES (2010)
Novel chemotherapeutic and renal protective effects for the green tea (EGCG): Role of oxidative stress and inflammatory-cytokine signaling
A. M. El-Mowafy et al.
PHYTOMEDICINE (2010)
Advanced glycation end products, oxidative stress and diabetic nephropathy
Sho-ichi Yamagishi et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2010)
Role of Differential Signaling Pathways and Oxidative Stress in Diabetic Cardiomyopathy
Kenichi Watanabe et al.
CURRENT CARDIOLOGY REVIEWS (2010)
Regulation of superoxide dismutase genes: Implications in disease
Lu Miao et al.
FREE RADICAL BIOLOGY AND MEDICINE (2009)
Reduction of Renal Superoxide Dismutase in Progressive Diabetic Nephropathy
Hiroki Fujita et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
10-year follow-up of intensive glucose control in type 2 diabetes
Rury R. Holman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
被撤回的出版物: Alpha-lipoic acid supplementation and diabetes (Retracted article. See vol. 70, pg. 482, 2012)
Uma Singh et al.
NUTRITION REVIEWS (2008)
Effects of green tea and EGCG on cardiovascular and metabolic health
Swen Wolfram
JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION (2007)
Protective effect of (-)-epigallocatechin gallate against advanced glycation endproducts-induced injury in neuronal cells
Sun-Joo Lee et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2007)
Oral treatment with α-lipoic acid improves symptomatic diabetic polyneuropathy -: The SYDNEY 2 trial
Dan Ziegler et al.
DIABETES CARE (2006)
Therapeutic potential of (-)-epigallocatechin 3-O-gallate on renal damage in diabetic nephropathy model rats
Noriko Yamabe et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Targeting multiple signaling pathways by green tea polyphenol (-)-epigallocatechin-3-gallate
N Khan et al.
CANCER RESEARCH (2006)
Advanced glycation end products and the kidney
JM Bohlender et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2005)
Diabetic vascular complications: Pathophysiology, biochemical basis and potential therapeutic strategy
S Yamagishi et al.
CURRENT PHARMACEUTICAL DESIGN (2005)
Attenuation of renal injury in db/db mice overexpressing superoxide dismutase -: Evidence for reduced superoxide-nitric oxide interaction
FR DeRubertis et al.
DIABETES (2004)
A phase II trial of green tea in the treatment of patients with androgen independent metastatic prostate carcinoma
A Jatoi et al.
CANCER (2003)
Assessing glycemic control in patients with diabetes and end-stage renal failure
A Ansari et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2003)
Effects of alpha lipoic acid, ascorbic acid-6-palmitate, and fish oil on the glutathione, malonaldehyde, and fatty acids levels in erythrocytes of streptozotocin induced diabetic male rats
O Yilmaz et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2002)
Share Paper
